TrialSignal transduction and targeted therapy2024

Penpulimab, an anti-PD-1 antibody, for heavily pretreated metastatic nasopharyngeal carcinoma: a single-arm phase II study.

Xiaozhong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.